The overexpression of EIF5A2 was associated with invasion, metastasis, and other malignant phenotypes of various cancers, suggesting that EIF5A2 may be a potential therapeutic target (Chen et al., 2018; Ba et al., 2019; Dong et al., 2019). This evidence concerns the gene EIF5A2 and cancer.